Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bagust

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Health Technology Assessment (Winchester, England)|June 15, 2004
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluationY Dündar, A Boland, J Strobl, et al.
Archives of Disease in Childhood|October 23, 2002
Randomised controlled trial comparing an acute paediatric hospital at home scheme with conventional hospital careS A Sartain, M J Maxwell, P J Todd, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2004
Evaluating the performance of the Framingham risk equations in a population with diabetesP McEwan, J E Williams, J D Griffiths, et al.
Health Technology Assessment (Winchester, England)|December 22, 2006
Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluationY Dundar, A Bagust, R Dickson, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancerT Brown, A Boland, A Bagust, et al.
Health Technology Assessment (Winchester, England)|November 15, 2007
Drug-eluting stents: a systematic review and economic evaluationR A Hill, A Boland, R Dickson, et al.
Health Technology Assessment (Winchester, England)|April 15, 2008
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluationJ C Hockenhull, K Dwan, A Boland, et al.
Health Technology Assessment (Winchester, England)|September 6, 2011
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysisJ Greenhalgh, A Bagust, A Boland, et al.
Health Technology Assessment (Winchester, England)|July 27, 2007
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluationC McLeod, A Bagust, A Boland, et al.
Health Technology Assessment (Winchester, England)|October 7, 2009
Rituximab for the treatment of rheumatoid arthritisA Bagust, A Boland, J Hockenhull, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Health Technology Assessment (Winchester, England)|June 15, 2004
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluationY Dündar, A Boland, J Strobl, et al.
Archives of Disease in Childhood|October 23, 2002
Randomised controlled trial comparing an acute paediatric hospital at home scheme with conventional hospital careS A Sartain, M J Maxwell, P J Todd, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2004
Evaluating the performance of the Framingham risk equations in a population with diabetesP McEwan, J E Williams, J D Griffiths, et al.
Health Technology Assessment (Winchester, England)|December 22, 2006
Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluationY Dundar, A Bagust, R Dickson, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancerT Brown, A Boland, A Bagust, et al.
Health Technology Assessment (Winchester, England)|November 15, 2007
Drug-eluting stents: a systematic review and economic evaluationR A Hill, A Boland, R Dickson, et al.
Health Technology Assessment (Winchester, England)|April 15, 2008
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluationJ C Hockenhull, K Dwan, A Boland, et al.
Health Technology Assessment (Winchester, England)|September 6, 2011
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysisJ Greenhalgh, A Bagust, A Boland, et al.
Health Technology Assessment (Winchester, England)|July 27, 2007
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluationC McLeod, A Bagust, A Boland, et al.
Health Technology Assessment (Winchester, England)|October 7, 2009
Rituximab for the treatment of rheumatoid arthritisA Bagust, A Boland, J Hockenhull, et al.
Pageof 6